predict • partner • prepare
March 2022, Angels for Change, announced a historic move to enter the grantmaking space to reduce patient-level impact of drug shortages.
“We are pleased to see the immediate impact this pilot has created for our hospitals. Children’s hospitals have been able to provide needed TPN and other life-saving electrolyte therapies during a time of urgent shortage. The net new supply has enabled our hospitals to ensure uninterrupted care for vulnerable patients.”
As of February 2022, Angels for Change announces that their first grant recipient STAQ Pharma, Inc. has already increased capacity and supply resulting in more than half a million life-saving treatments.
“Since our founding, Angels for Change has been ending drug shortages for our most vulnerable patients. As we work to end all healthcare crises created by drug shortages, we are advocating for, and supporting, proactive, public-private partnerships at the beginning of the supply chain to create more resiliency reducing patient impact,” Said Laura Bray, founder and Chief Change Maker at Angels for Change.
CURRENT PROJECTS
We are currently accepting grant applications for project PROTECT to protect the following Essential Medicines from drug shortage. For more information please contact us at communications@angelsforchange.org.
Levetiracetam
Bumetanide
Grant Awarded in Production
Dextrose
Grant Awarded in Production
Furosemide
Grant Awarded in Production
POTASSIUM
Grant Awarded in Production
Potassium Chloride
PROTECTed till 2024
Fat Emulsions
Leucovorin Calcium
Calcium Chloride
Grant Awarded in Production
Magnesium
Grant Awarded in Production
Sodium Phosphate
Grant Awarded in Production
Sodium
chloride
PROTECTed till 2024
PROTECTED DRUGS
Below is a list of drugs that have been protected with the help of our Change Makers.
Over half a million treatments have been accessed so far.
Potassium Chloride
Sodium Chloride
